Gerburg M. Wulf

Also affiliated with Harvard University, Dana-Farber Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

5in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 5 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Supplementary Figure S3 from Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models

10.1158/2767-9764.25976510

Top 100%

0DataRank

Top 100%0 citations

Jingqin Luo, R. Jay Mashl, Jeremy Hoog, Piyush Maiti, Nicole Fettig +11 more

Papers

Driven by 33 papers — median percentile 0. Top paper: “Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer”.

Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer

Nature Communications(2021)10.1038/s41467-021-25769-z

N/A

1.8DataRank · unranked

48 citations

Jennifer L. Guerriero, Romualdo Barroso‐Sousa, Tianyu Li, Tess A. O’Meara, Anita Giobbie‐Hurder +24 more

Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3045

N/A

1.5DataRank · unranked

64 citations

Niya Xiong, Nabihah Tayob, Madeline Polak, Julia Eismann, Lewis C. Cantley +10 more

Phase Ib study of pembrolizumab in combination with trastuzumab emtansine for metastatic HER2-positive breast cancer

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005119

N/A

1.2DataRank · unranked

39 citations

Tanya E. Keenan, Tianyu Li, Nabihah Tayob, Gerburg M. Wulf, Edward T. Richardson +10 more

PARP-inhibition reprograms macrophages toward an anti-tumor phenotype

Cell Reports(2022)10.1016/j.celrep.2022.111462

N/A

1.1DataRank · unranked

57 citations

Dan Wang, Olmo Sonzogni, Shizhong Ke, Qi Wang, Abhishek Thavamani +17 more

Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach

iScience(2022)10.1016/j.isci.2022.105799

N/A

0.830DataRank · unranked

35 citations

Lacey E. Dobrolecki, Lillian Ashmore, Alaina Lewis, Christina Sallas, Ramakrishnan Rajaram Srinivasan +25 more

An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers

BMC Cancer(2020)10.1186/s12885-020-6605-1

N/A

0.646DataRank · unranked

34 citations

Thomas A. Davis, Abdelrahman Hosny, Julia Eismann, Ursula A. Matulonis, Gerburg M. Wulf +2 more

WWP1 inactivation enhances efficacy of PI3K inhibitors while suppressing their toxicities in breast cancer models

Journal of Clinical Investigation(2021)10.1172/jci140436

N/A

0.470DataRank · unranked

22 citations

Hiroshi Higuchi, Limei Wang, Nivedita Panch, Valerie Maymi, Sachem Best +12 more

Visualizing the effects of lactate dehydrogenase (LDH) inhibition and LDH‐A genetic ablation in breast and lung cancer with hyperpolarized pyruvate NMR

NMR in Biomedicine(2021)10.1002/nbm.4560

N/A

0.464DataRank · unranked

21 citations

Pankaj Seth, Patrícia Coutinho de Souza, Cody Callahan, Jocelin Pinto, Manushka Vaidya +5 more

A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancer

EBioMedicine(2025)10.1016/j.ebiom.2025.105828

N/A

0.404DataRank · unranked

7 citations

Rosario Chica-Parrado, Caroline Weipert, Todd C. Knepper, Emily Podany, Fabiana Napolitano +21 more

Effect of testosterone therapy on breast tissue composition and mammographic breast density in trans masculine individuals

Breast Cancer Research(2024)10.1186/s13058-024-01867-w

N/A

0.392DataRank · unranked

10 citations

Gabrielle M. Baker, Valerie Fein‐Zachary, Yaileen D. Guzmán‐Arocho, Vanessa C. Bret-Mounet, Erica S. Massicott +13 more

A phase I/II trial evaluating the safety and efficacy of eribulin in combination with copanlisib in patients with metastatic triple-negative breast cancer (TNBC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps1128

N/A

0.241DataRank · unranked

4 citations

Leslie Nehring, J. L. Anderson, Brittney Haas, Jingqin Luo, Meghna S. Trivedi +10 more

Targeting transcription factors through an IMiD independent zinc finger domain

EMBO Molecular Medicine(2025)10.1038/s44321-025-00241-3

N/A

0.241DataRank · unranked

4 citations

Miao Liu, R. Sridhar, Mengyuan Dai, Chaitanya K. Jaladanki, Chong Gao +23 more

Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0047

N/A

0.208DataRank · unranked

3 citations

Jingqin Luo, R. Jay Mashl, Jeremy Hoog, Piyush Maiti, Nikki Fettig +11 more

Association of KMT2C loss-of-function mutations in circulating tumor DNA and prolonged response to the combination of PARPi and PI3Ki.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e13003

N/A

0.104DataRank · unranked

1 citations

Shizong Ke, Ruolin Liu, Tim Blewett, Justin Rhoades, D. Gulhan +5 more

Sensitive Multiplexed MicroRNA Spatial Profiling and Data Classification Framework Applied to Murine Breast Tumors

Analytical Chemistry(2024)10.1021/acs.analchem.4c01773

N/A

0DataRank · unranked

6 citations

Yujing J. Heng, Lin Wang, Abhishek Thavamani, Erica S. Massicott, Gerburg M. Wulf +3 more

Effect of testosterone therapy on breast tissue composition and mammographic breast density in trans masculine individuals

medRxiv(2024)10.1101/2024.01.09.24300987

N/A

0DataRank · unranked

1 citations

Gabrielle M. Baker, Valerie Fein‐Zachary, Yaileen D. Guzmán‐Arocho, Vanessa C. Bret-Mounet, Erica S. Massicott +11 more

Supplementary Figure S3 from Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models

10.1158/2767-9764.25976510

Top 100%

0DataRank

Top 100%0 citations

Jingqin Luo, R. Jay Mashl, Jeremy Hoog, Piyush Maiti, Nicole Fettig +11 more

FIGURE 3 from Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models

10.1158/2767-9764.25976528

N/A

0DataRank · unranked

0 citations

Jingqin Luo, R. Jay Mashl, Jeremy Hoog, Piyush Maiti, Nicole Fettig +11 more

The INPP4B Tumor Suppressor Modulates EGFR Trafficking and Promotes Triple-Negative Breast Cancer

Cancer Discovery(2020)10.1158/2159-8290.cd-19-1262

N/A

0DataRank · unranked

57 citations

Marcia N. Paddock, Haibin Wang, Charles J. Murphy, Renee C. Geck, Adrija J. Navarro +6 more

Supplementary Figure S1 from Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models

10.1158/2767-9764.25976516

N/A

0DataRank · unranked

0 citations

Jingqin Luo, R. Jay Mashl, Jeremy Hoog, Piyush Maiti, Nicole Fettig +11 more

Epstein–Barr Virus Infection of Mammary Epithelial Cells Promotes Malignant Transformation

UNC Libraries(2020)10.17615/s4pm-ws17

N/A

0DataRank · unranked

11 citations

Gerburg M. Wulf, Hai Hu, Edward Gabrielson, Xin Yuan, Man‐Li Luo +10 more

Trial in progress: A phase II open-label, randomized study of PARP inhibition (olaparib) either alone or in combination with anti-PD-L1 therapy (atezolizumab) in homologous DNA repair (HDR) deficient, locally advanced or metastatic non-HER2-positive breast cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps1102

N/A

0DataRank · unranked

10 citations

Mary Josephine Paula Pilat, Cesar Augusto Santa-Maria, Roisín M. Connolly, Erin Roesch, Anosheh Afghahi +15 more

Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy

Cell(2021)10.1016/j.cell.2021.07.020

N/A

0DataRank · unranked

244 citations

Shin Kibe, Futoshi Suizu, Nobufumi Sekino, Nami Kim, Theresa Manz +22 more

Blockade of 6-phosphogluconate dehydrogenase generates CD8+ effector T cells with enhanced anti-tumor function

Cell Reports(2021)10.1016/j.celrep.2021.108831

N/A

0DataRank · unranked

52 citations

Teresa Cassel, Penghui Lin, Richard M. Higashi, Gerburg M. Wulf, Vassiliki A. Boussiotis +3 more

A Network Approach to Identify Biomarkers of Differential Chemotherapy Response Using Patient-Derived Xenografts of Triple-Negative Breast Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.08.20.457116

N/A

0DataRank · unranked

5 citations

Lacey E. Dobrolecki, Lillian Ashmore, Alaina Lewis, Christina Sallas, Ramakrishnan Rajaram +19 more

STING agonism enhances anti-tumor immune responses and therapeutic efficacy of PARP inhibition in BRCA-associated breast cancer

npj Breast Cancer(2022)10.1038/s41523-022-00471-5

N/A

0DataRank · unranked

35 citations

Heta Jadhav, Aditi Kothari, Renyan Liu, Gerburg M. Wulf, Jennifer L. Guerriero +2 more

A 13C/31P surface coil to visualize metabolism and energetics in the rodent brain at 3 Tesla

Journal of Magnetic Resonance(2022)10.1016/j.jmr.2022.107286

N/A

0DataRank · unranked

0 citations

Bei Zhang, Donghyun Hong, Ryan Brown, Georgios Batsios, Pavithra Viswanath +6 more

Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA Mutations

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0704

N/A

0DataRank · unranked

61 citations

Ferran Fece de la Cruz, Elizabeth E. Martin, Bryanna L. Norden, Nicholas Chevalier, Allison M. Kehlmann +26 more

Simultaneous isolation of hormone receptor–positive breast cancer organoids and fibroblasts reveals stroma-mediated resistance mechanisms

Journal of Biological Chemistry(2023)10.1016/j.jbc.2023.105021

N/A

0DataRank · unranked

28 citations

Kayla Cruz, Laura M. Selfors, Madelyn N. Ward, Tejas S. Mehta, Naama Kanarek +7 more

RETRACTED ARTICLE: Polymerase θ inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer

Nature Communications(2023)10.1038/s41467-023-37096-6

N/A

0DataRank · unranked

22 citations

Heta Jadhav, Constantia Pantelidou, Tin Phan, Carter Grochala, Anita K. Mehta +9 more

Data from Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6532290.v1

Top 100%

0DataRank

Top 100%0 citations

Niya Xiong, Nabihah Tayob, Madeline Polak, Julia Eismann, Lewis C. Cantley +10 more

Data from Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6532290

Top 100%

0DataRank

Top 100%0 citations

Niya Xiong, Nabihah Tayob, Madeline Polak, Julia Eismann, Lewis C. Cantley +10 more

Data from Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers

(2023)10.1158/1078-0432.c.6532794

N/A

0DataRank · unranked

0 citations

D. Gulhan, Victor Y. Mao, Antuan V. Tran, Madeline Polak, Niya Xiong +14 more

Gerburg M. Wulf

Indexed papers

Top data-sharing exemplar

Papers